Table II.
Factor | Experimental cells | Effect on melanogenesis | Mechanisms | (Refs.) |
---|---|---|---|---|
IL-18 | Keratinocyte | Promotion | Increasing tyrosinase activity and upregulating TYRP-1 and TYRP-2 expression | (43) |
IL-33 | Melanocytes | Promotion | Promoting MITF, TYR, TYRP-1, TYRP-2 expression by activating the p38/MAPK and PKA pathways | (14) |
GM-CSF | Melanocytes | Promotion | Promoting melanocyte proliferation and melanin synthesis | (17) |
PGE2 and PGF2α | Keratinocytes | Promotion | Stimulating melanocyte dendrite formation through a cAMP-dependent pathway | (62) |
IFN-γ | B16F10 | Inhibition | Blocking maturation of melanosome and upregulating STAT1 phosphorylation | (46,72) |
TNF | Melanocytes, primary pooled human keratinocytes | Inhibition | Inhibiting melanin formation through PKA and MAPK signaling pathways in combination with IL-17 | (10) |
IL-1α | Primary melanocytes, swine skin | Promotion | Combination of KGF increases melanin deposition | (79) |
IL-1β | Melanoma cell lines (LB2259-MEL and CP50-MEL) | Inhibition | Downregulating MITF-M expression through NF-κB and JNK pathways | (74) |
IL-4 | Melanocytes | Inhibition | Downregulating the expression of MITF, TYRP-1, TYRP-2 through the JAK2-STAT6 signaling pathway | (13) |
IL-6 | Melanocytes | Inhibition | Decreasing tyrosinase activity | (12) |
IL-17 | Melanocytes, primary pooled human keratinocytes | Inhibition | Inhibiting melanin formation through PKA and MAPK signaling pathways in combination with TNF | (10) |
TYRP-1, tyrosinase-related protein-1; TYRP-2, tyrosinase-related protein-2; MITF, microphthalmia-associated transcription factor; TYR, tyrosinase; PKA, protein kinase A; MAPK, mitogen activated protein kinase; JNK, c-Jun N-terminal kinase; JAK-STAT, Janus kinase-signal transducer and activator of transcription.